Albert S. Baldwin

Active 1984–2025

149
Papers
48,205
Citations
106
h-index
147
i10-index

Citations

Citations per year for Albert S. Baldwin1984: 1 citations1985: 18 citations1986: 22 citations1987: 45 citations1988: 113 citations1989: 139 citations1990: 149 citations1991: 116 citations1992: 134 citations1993: 137 citations1994: 183 citations1995: 287 citations1996: 276 citations1997: 461 citations1998: 600 citations1999: 896 citations2000: 898 citations2001: 932 citations2002: 945 citations2003: 989 citations2004: 1,022 citations2005: 762 citations2006: 700 citations2007: 564 citations2008: 532 citations2009: 489 citations2010: 477 citations2011: 396 citations2012: 394 citations2013: 375 citations2014: 304 citations2015: 289 citations2016: 226 citations2017: 234 citations2018: 220 citations2019: 740 citations2020: 798 citations2021: 709 citations2022: 521 citations2023: 363 citations2024: 600 citations2025: 280 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,687 citing papers, 38.2% of this breakdownChina: 1,706 citing papers, 9.8% of this breakdownGermany: 1,009 citing papers, 5.8% of this breakdownUnited Kingdom: 914 citing papers, 5.2% of this breakdownJapan: 680 citing papers, 3.9% of this breakdownCanada: 584 citing papers, 3.3% of this breakdownItaly: 550 citing papers, 3.1% of this breakdownFrance: 525 citing papers, 3% of this breakdownSouth Korea: 471 citing papers, 2.7% of this breakdownIndia: 327 citing papers, 1.9% of this breakdownSpain: 326 citing papers, 1.9% of this breakdownAustralia: 324 citing papers, 1.9% of this breakdown
0%38.2%Other 19.3%

Fields

  • Biochemistry, Genetics and Molecular Biology50.8%
  • Medicine30.5%
  • Immunology and Microbiology10.9%
  • Neuroscience3.1%
  • Agricultural and Biological Sciences1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Other2.5%

Topics

  • NF-κB Signaling Pathways9.3%
  • Immune Response and Inflammation4.7%
  • Cell death mechanisms and regulation3%
  • Cytokine Signaling Pathways and Interactions2.9%
  • interferon and immune responses2%
  • Ubiquitin and proteasome pathways1.8%
  • Other76.3%

Coauthors

All papers

Open in search
  1. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xing Chang, Yufeng Zhou, Li Shen, Albert S. Baldwin, Kun‐Liang Guan, Yue Xiong, Dan Ye - Nature Cell Biology 2022 cited by 206

  2. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

    Authors: - Annual Review of Immunology 1996 cited by 5,964

  3. Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK

    Authors: , , , , , - Genes & Development 2008 cited by 637

  4. NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1

    Authors: , , , , - Molecular and Cellular Biology 1999 cited by 1,301

  5. TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss

    Authors: , , , , , , , , , , , , , , , - Cancer Discovery 2019 cited by 108

  6. The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression

    Authors: , , - Molecular and Cellular Biology 2001 cited by 732

  7. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William G. Kaelin, Albert S. Baldwin, Qing Zhang - Science 2018 cited by 221

  8. Expanding the View of IKK: New Substrates and New Biology

    Authors: , , - Trends in Cell Biology 2021 cited by 101

  9. NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation

    Authors: , , , , - Science 1998 cited by 2,720

  10. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression

    Authors: , - Oncogene 2006 cited by 668

  11. NF-κB-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia

    Authors: , , , , - Science 2000 cited by 922

  12. Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer

    Authors: - Immunological Reviews 2012 cited by 276

  13. The NF-κB Pathway and Cancer Stem Cells

    Authors: , - Cells 2016 cited by 251

  14. Apoptotic cells induce Mer tyrosine kinase–dependent blockade of NF-κB activation in dendritic cells

    Authors: , , , , , , , , , - Blood 2006 cited by 231

  15. Akt-dependent Activation of mTORC1 Complex Involves Phosphorylation of mTOR (Mammalian Target of Rapamycin) by IκB Kinase α (IKKα)

    Authors: , , , , , - Journal of Biological Chemistry 2014 cited by 164

  16. Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 106

  17. Histone H3 proline 16 hydroxylation regulates mammalian gene expression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2022 cited by 50

  18. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

    Authors: , , , - Science 1995 cited by 1,724

  19. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

    Authors: , , , - Nature Medicine 1999 cited by 994

  20. Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression

    Authors: , , , - The EMBO Journal 2005 cited by 236

  21. TBK1 Limits mTORC1 by Promoting Phosphorylation of Raptor Ser877

    Authors: , , , , , , , - Scientific Reports 2019 cited by 40

  22. Enabling Genetic Code Expansion and Peptide Macrocyclization in mRNA Display via a Promiscuous Orthogonal Aminoacyl-tRNA Synthetase

    Authors: , , , , , , , - Journal of the American Chemical Society 2023 cited by 30

  23. NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis

    Authors: , , , - Molecular and Cellular Biology 1999 cited by 586

  24. Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma

    Authors: , , , , , , , , - Nature Communications 2016 cited by 127